drugset / Trial / NCT02071394

Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth

NCT02071394

RandomizedParallel-groupOpen-labelTreatment

Summary

This study examines the effect of inhaled xenon gas in the treatment of newborn infants with hypoxic-ischemic encephalopathy (HIE) in combination with cooling, which is the standard treatment for this condition. The hypothesis is that the xenon + cooling combination will produce better neuroprotection than the standard treatment of cooling alone.

Timeline

Start
2014-03
Primary completion
2019-10-07
Completion
2020-04-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Xenon Other / unclassified 50 % Inhaled